Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EpicentRx announces positive results from phase 1 trial of RRx-001 as first-line treatment in newly diagnosed glioblastoma
EpicentRx announces positive results from phase 1 trial of RRx-001 as first-line treatment in newly diagnosed glioblastoma. Photo: courtesy of PublicDomainPictures from Pixabay.